Delivery Order SPE2DB24D9144-SPE2DB25FCMRR
Award Date 5/12/25
Potential Completion Date 5/13/25
Potential Value $4.3K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $4,311.35 to DMS Pharmaceutical Group Inc. on September 3, 2025, for the supply of Xtandi 40 mg capsules (120-count units). DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will fulfill this order for delivery to Park Ridge, IL. The contract utilizes a firm fixed-price structure with an ultimate completion date of September 4, 2025, and no set-aside designation...
- The Defense Logistics Agency awarded a delivery order valued at $4,311.35 to DMS Pharmaceutical Group Inc. for 120 capsules of Xtandi 40 mg on September 15, 2025, with completion targeted for September 16, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected under a firm fixed-price delivery order contract with no set-aside designation. The order will be fulfilled from the contractor's Park Ridge, Illinois...
- The Defense Logistics Agency awarded a delivery order valued at $8,480.94 to DMS Pharmaceutical Group Inc. for the supply of Xtandi 40 mg capsules (120-count units) on May 6, 2025, with an ultimate completion date of May 7, 2025. This firm fixed-price delivery order was issued without set-aside designation and is being performed in Park Ridge, Illinois, where the vendor is based. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is the awardee under its...
- The Defense Logistics Agency awarded a delivery order valued at $4,311.35 to DMS Pharmaceutical Group Inc. for the supply of Xtandi 40 mg capsules (120-count units) on September 15, 2025, with an ultimate completion date of September 16, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a single transaction under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA valued at $500 million through November 2026. The contractor, a...
- The Defense Logistics Agency issued a firm fixed-price delivery order valued at $12,792.31 to DMS Pharmaceutical Group Inc. for the supply of Xtandi 40 mg capsules (120-count units). DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its Park Ridge location with completion expected by July 24, 2025. This delivery order was awarded without a set-aside designation, allowing the vendor to compete in the open...
- The Defense Logistics Agency awarded a delivery order valued at $12,934.05 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xtandi 40 mg capsules (quantity: 120). This firm fixed-price delivery order, issued on July 21, 2025, with an ultimate completion date of July 22, 2025, represents a continuation of the ongoing pharmaceutical supply relationship between the agency and the vendor. The award carries no...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $8,622.72 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xtandi 40 mg capsules (120 count). This delivery order, issued on September 26, 2025, with an ultimate completion date of September 29, 2025, carries no set-aside designation, allowing the vendor to compete on an unrestricted basis despite its small business status....
- The U.S. Defense Logistics Agency (DLA), through the Medical Supply Chain division, awarded a delivery order to DMS Pharmaceutical Group Inc. on August 25, 2025, for the supply of Xtandi 40 mg capsules (120 count units) valued at $4,311.35. This firm fixed-price delivery order, issued under no set-aside designation, is scheduled for completion by August 26, 2025, with fulfillment from the vendor's Park Ridge, Illinois location. DMS Pharmaceutical Group Inc., a woman-owned small business...
- The Defense Logistics Agency awarded a $4,311.35 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xtandi 40 mg capsules (120-count units). The award, issued on September 26, 2025, with an ultimate completion date of September 29, 2025, carries no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $17,245.40 to DMS Pharmaceutical Group Inc. for the supply of Xtandi 40 mg capsules (120-count units). This award, issued on September 11, 2025, with an ultimate completion date of September 12, 2025, represents a single delivery order under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA. The contract carries no set-aside designation, and the product will be delivered to Park Ridge,...